|
IMPAD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.97119999989503E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78369985448512E-10 |
| Normal-vs-Stage2 |
3.056900E-03 |
| Normal-vs-Stage3 |
6.500000E-02 |
| Normal-vs-Stage4 |
7.184600E-04 |
| Stage1-vs-Stage2 |
3.157200E-01 |
| Stage1-vs-Stage3 |
2.120200E-01 |
| Stage1-vs-Stage4 |
2.288800E-01 |
| Stage2-vs-Stage3 |
6.682600E-01 |
| Stage2-vs-Stage4 |
9.940200E-01 |
| Stage3-vs-Stage4 |
6.542000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.46670000000793E-06 |
| Normal-vs-AfricanAmerican |
2.67940003517708E-10 |
| Normal-vs-Asian |
3.763800E-02 |
| Caucasian-vs-AfricanAmerican |
5.040800E-03 |
| Caucasian-vs-Asian |
8.840400E-01 |
| AfricanAmerican-vs-Asian |
3.676800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14510000004397E-06 |
| Normal-vs-Female |
2.49100000004887E-06 |
| Male-vs-Female |
6.220400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.966600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.31039999962113E-07 |
| Normal-vs-Age(61-80Yrs) |
7.62730000000156E-05 |
| Normal-vs-Age(81-100Yrs) |
1.437210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.349000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.356400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.649200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.405800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.891200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.621800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.438600E-03 |
| Normal-vs-Grade 2 |
2.191700E-04 |
| Normal-vs-Grade 3 |
6.55499999835385E-08 |
| Normal-vs-Grade 4 |
2.099900E-03 |
| Grade 1-vs-Grade 2 |
7.279000E-01 |
| Grade 1-vs-Grade 3 |
9.504400E-01 |
| Grade 1-vs-Grade 4 |
5.038800E-01 |
| Grade 2-vs-Grade 3 |
4.814800E-01 |
| Grade 2-vs-Grade 4 |
5.211000E-01 |
| Grade 3-vs-Grade 4 |
1.116990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.37889954799198E-10 |
| Normal-vs-ccB subtype |
1.498640E-01 |
| ccA subtype-vs-ccB subtype |
4.676300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.036100E-04 |
| Normal-vs-N1 |
3.585800E-01 |
| N0-vs-N1 |
6.730200E-01 |
|
|
